*it’s possible that you receive an intermediate validation email
AbbVie SA/NV - BE-ABBV-210114 (v1.0) - August 21
You are now leaving the AbbVie Pro Portal and being re-directed to an external website. The information you are about to be referred to may not comply with the Belgium regulatory requirements.
Do you wish to continue?